nodes	percent_of_prediction	percent_of_DWPC	metapath
Cilazapril—ABCB1—colon cancer	0.714	1	CbGaD
Cilazapril—ACE—vein—colon cancer	0.0164	0.195	CbGeAlD
Cilazapril—ACE—umbilical vein—colon cancer	0.0119	0.141	CbGeAlD
Cilazapril—ACE—endothelium—colon cancer	0.00564	0.067	CbGeAlD
Cilazapril—ACE—blood vessel—colon cancer	0.0052	0.0618	CbGeAlD
Cilazapril—ABCB1—Irinotecan—colon cancer	0.00481	0.416	CbGbCtD
Cilazapril—ABCB1—Vincristine—colon cancer	0.0042	0.364	CbGbCtD
Cilazapril—SLC15A1—epithelium—colon cancer	0.00353	0.0419	CbGeAlD
Cilazapril—SLC15A1—renal system—colon cancer	0.00328	0.0389	CbGeAlD
Cilazapril—ACE—embryo—colon cancer	0.0031	0.0368	CbGeAlD
Cilazapril—SLC15A1—digestive system—colon cancer	0.00269	0.0319	CbGeAlD
Cilazapril—ABCB1—Methotrexate—colon cancer	0.00254	0.22	CbGbCtD
Cilazapril—ACE—epithelium—colon cancer	0.00253	0.0301	CbGeAlD
Cilazapril—ACE—smooth muscle tissue—colon cancer	0.00244	0.029	CbGeAlD
Cilazapril—SLC15A1—vagina—colon cancer	0.00237	0.0282	CbGeAlD
Cilazapril—ACE—renal system—colon cancer	0.00235	0.0279	CbGeAlD
Cilazapril—Mitiglinide—PPARG—colon cancer	0.0022	0.391	CrCbGaD
Cilazapril—SLC15A2—renal system—colon cancer	0.00205	0.0243	CbGeAlD
Cilazapril—SLC15A1—liver—colon cancer	0.002	0.0238	CbGeAlD
Cilazapril—ACE—lymphoid tissue—colon cancer	0.00195	0.0232	CbGeAlD
Cilazapril—ACE—digestive system—colon cancer	0.00193	0.0229	CbGeAlD
Cilazapril—ABCB1—blood vessel—colon cancer	0.00183	0.0217	CbGeAlD
Cilazapril—ACE—bone marrow—colon cancer	0.00178	0.0211	CbGeAlD
Cilazapril—SLC15A2—vagina—colon cancer	0.00148	0.0176	CbGeAlD
Cilazapril—ACE—liver—colon cancer	0.00144	0.017	CbGeAlD
Cilazapril—Nateglinide—PPARG—colon cancer	0.00112	0.199	CrCbGaD
Cilazapril—ACE—lymph node—colon cancer	0.0011	0.0131	CbGeAlD
Cilazapril—ABCB1—embryo—colon cancer	0.00109	0.013	CbGeAlD
Cilazapril—SLC15A2—lymph node—colon cancer	0.00096	0.0114	CbGeAlD
Cilazapril—Perindopril—ABCB1—colon cancer	0.000913	0.162	CrCbGaD
Cilazapril—ABCB1—epithelium—colon cancer	0.000891	0.0106	CbGeAlD
Cilazapril—ABCB1—renal system—colon cancer	0.000827	0.00982	CbGeAlD
Cilazapril—Lisinopril—ABCB1—colon cancer	0.000804	0.143	CrCbGaD
Cilazapril—ABCB1—lymphoid tissue—colon cancer	0.000687	0.00815	CbGeAlD
Cilazapril—ABCB1—digestive system—colon cancer	0.000678	0.00805	CbGeAlD
Cilazapril—ABCB1—bone marrow—colon cancer	0.000625	0.00742	CbGeAlD
Cilazapril—ABCB1—vagina—colon cancer	0.000599	0.00711	CbGeAlD
Cilazapril—Enalapril—ABCB1—colon cancer	0.00059	0.105	CrCbGaD
Cilazapril—Ill-defined disorder—Irinotecan—colon cancer	0.00054	0.00293	CcSEcCtD
Cilazapril—Anaemia—Irinotecan—colon cancer	0.000537	0.00292	CcSEcCtD
Cilazapril—Bronchitis—Capecitabine—colon cancer	0.000537	0.00291	CcSEcCtD
Cilazapril—Vertigo—Vincristine—colon cancer	0.000536	0.00291	CcSEcCtD
Cilazapril—Leukopenia—Vincristine—colon cancer	0.000534	0.0029	CcSEcCtD
Cilazapril—Malaise—Irinotecan—colon cancer	0.000524	0.00285	CcSEcCtD
Cilazapril—Vertigo—Irinotecan—colon cancer	0.000522	0.00283	CcSEcCtD
Cilazapril—Dysuria—Capecitabine—colon cancer	0.000522	0.00283	CcSEcCtD
Cilazapril—Neutropenia—Capecitabine—colon cancer	0.000522	0.00283	CcSEcCtD
Cilazapril—Syncope—Irinotecan—colon cancer	0.000521	0.00283	CcSEcCtD
Cilazapril—Renal failure acute—Methotrexate—colon cancer	0.000521	0.00283	CcSEcCtD
Cilazapril—Leukopenia—Irinotecan—colon cancer	0.000521	0.00282	CcSEcCtD
Cilazapril—Hypertension—Vincristine—colon cancer	0.000516	0.0028	CcSEcCtD
Cilazapril—Anaemia—Fluorouracil—colon cancer	0.000515	0.00279	CcSEcCtD
Cilazapril—Loss of consciousness—Irinotecan—colon cancer	0.000511	0.00277	CcSEcCtD
Cilazapril—Photosensitivity reaction—Capecitabine—colon cancer	0.00051	0.00277	CcSEcCtD
Cilazapril—Myalgia—Vincristine—colon cancer	0.000508	0.00276	CcSEcCtD
Cilazapril—Cough—Irinotecan—colon cancer	0.000507	0.00275	CcSEcCtD
Cilazapril—ABCB1—liver—colon cancer	0.000505	0.006	CbGeAlD
Cilazapril—Hyperglycaemia—Capecitabine—colon cancer	0.000504	0.00273	CcSEcCtD
Cilazapril—Hypertension—Irinotecan—colon cancer	0.000502	0.00272	CcSEcCtD
Cilazapril—Leukopenia—Fluorouracil—colon cancer	0.000499	0.0027	CcSEcCtD
Cilazapril—Stevens-Johnson syndrome—Capecitabine—colon cancer	0.000494	0.00268	CcSEcCtD
Cilazapril—Acute coronary syndrome—Capecitabine—colon cancer	0.000491	0.00266	CcSEcCtD
Cilazapril—Cerebrovascular accident—Methotrexate—colon cancer	0.000491	0.00266	CcSEcCtD
Cilazapril—Renal failure—Capecitabine—colon cancer	0.00049	0.00266	CcSEcCtD
Cilazapril—Discomfort—Irinotecan—colon cancer	0.000489	0.00265	CcSEcCtD
Cilazapril—Myocardial infarction—Capecitabine—colon cancer	0.000488	0.00265	CcSEcCtD
Cilazapril—Oedema—Vincristine—colon cancer	0.000487	0.00264	CcSEcCtD
Cilazapril—Conjunctivitis—Capecitabine—colon cancer	0.000484	0.00263	CcSEcCtD
Cilazapril—Confusional state—Irinotecan—colon cancer	0.000479	0.0026	CcSEcCtD
Cilazapril—Thrombocytopenia—Vincristine—colon cancer	0.000477	0.00259	CcSEcCtD
Cilazapril—Oedema—Irinotecan—colon cancer	0.000475	0.00258	CcSEcCtD
Cilazapril—Chest pain—Fluorouracil—colon cancer	0.000474	0.00257	CcSEcCtD
Cilazapril—Myalgia—Fluorouracil—colon cancer	0.000474	0.00257	CcSEcCtD
Cilazapril—Hyperhidrosis—Vincristine—colon cancer	0.000471	0.00256	CcSEcCtD
Cilazapril—Hepatobiliary disease—Capecitabine—colon cancer	0.000471	0.00256	CcSEcCtD
Cilazapril—Epistaxis—Capecitabine—colon cancer	0.00047	0.00255	CcSEcCtD
Cilazapril—Discomfort—Fluorouracil—colon cancer	0.000468	0.00254	CcSEcCtD
Cilazapril—Shock—Irinotecan—colon cancer	0.000467	0.00253	CcSEcCtD
Cilazapril—Agranulocytosis—Capecitabine—colon cancer	0.000465	0.00252	CcSEcCtD
Cilazapril—Thrombocytopenia—Irinotecan—colon cancer	0.000465	0.00252	CcSEcCtD
Cilazapril—Anorexia—Vincristine—colon cancer	0.000465	0.00252	CcSEcCtD
Cilazapril—Hyperhidrosis—Irinotecan—colon cancer	0.000459	0.00249	CcSEcCtD
Cilazapril—Confusional state—Fluorouracil—colon cancer	0.000458	0.00249	CcSEcCtD
Cilazapril—Hypotension—Vincristine—colon cancer	0.000455	0.00247	CcSEcCtD
Cilazapril—Bradycardia—Capecitabine—colon cancer	0.000455	0.00247	CcSEcCtD
Cilazapril—Oedema—Fluorouracil—colon cancer	0.000455	0.00247	CcSEcCtD
Cilazapril—Anorexia—Irinotecan—colon cancer	0.000452	0.00245	CcSEcCtD
Cilazapril—Ataxia—Methotrexate—colon cancer	0.000452	0.00245	CcSEcCtD
Cilazapril—Rhinitis—Capecitabine—colon cancer	0.000448	0.00243	CcSEcCtD
Cilazapril—Thrombocytopenia—Fluorouracil—colon cancer	0.000445	0.00241	CcSEcCtD
Cilazapril—Hypoaesthesia—Capecitabine—colon cancer	0.000445	0.00241	CcSEcCtD
Cilazapril—Liver function test abnormal—Methotrexate—colon cancer	0.000444	0.00241	CcSEcCtD
Cilazapril—Musculoskeletal discomfort—Vincristine—colon cancer	0.000444	0.00241	CcSEcCtD
Cilazapril—Pharyngitis—Capecitabine—colon cancer	0.000444	0.00241	CcSEcCtD
Cilazapril—Tachycardia—Fluorouracil—colon cancer	0.000444	0.00241	CcSEcCtD
Cilazapril—Hypotension—Irinotecan—colon cancer	0.000443	0.00241	CcSEcCtD
Cilazapril—Urinary tract disorder—Capecitabine—colon cancer	0.000442	0.0024	CcSEcCtD
Cilazapril—Insomnia—Vincristine—colon cancer	0.000441	0.00239	CcSEcCtD
Cilazapril—Urethral disorder—Capecitabine—colon cancer	0.000438	0.00238	CcSEcCtD
Cilazapril—Paraesthesia—Vincristine—colon cancer	0.000438	0.00237	CcSEcCtD
Cilazapril—Anorexia—Fluorouracil—colon cancer	0.000433	0.00235	CcSEcCtD
Cilazapril—Toxic epidermal necrolysis—Methotrexate—colon cancer	0.000433	0.00235	CcSEcCtD
Cilazapril—Visual impairment—Capecitabine—colon cancer	0.000431	0.00234	CcSEcCtD
Cilazapril—Insomnia—Irinotecan—colon cancer	0.000429	0.00233	CcSEcCtD
Cilazapril—Paraesthesia—Irinotecan—colon cancer	0.000426	0.00231	CcSEcCtD
Cilazapril—Hypotension—Fluorouracil—colon cancer	0.000425	0.0023	CcSEcCtD
Cilazapril—Decreased appetite—Vincristine—colon cancer	0.000424	0.0023	CcSEcCtD
Cilazapril—Dyspnoea—Irinotecan—colon cancer	0.000423	0.0023	CcSEcCtD
Cilazapril—Erythema multiforme—Capecitabine—colon cancer	0.000423	0.00229	CcSEcCtD
Cilazapril—Somnolence—Irinotecan—colon cancer	0.000422	0.00229	CcSEcCtD
Cilazapril—Gastrointestinal disorder—Vincristine—colon cancer	0.000421	0.00228	CcSEcCtD
Cilazapril—Fatigue—Vincristine—colon cancer	0.00042	0.00228	CcSEcCtD
Cilazapril—Dyspepsia—Irinotecan—colon cancer	0.000418	0.00227	CcSEcCtD
Cilazapril—Tinnitus—Capecitabine—colon cancer	0.000417	0.00226	CcSEcCtD
Cilazapril—Pain—Vincristine—colon cancer	0.000417	0.00226	CcSEcCtD
Cilazapril—Constipation—Vincristine—colon cancer	0.000417	0.00226	CcSEcCtD
Cilazapril—Cardiac disorder—Capecitabine—colon cancer	0.000415	0.00225	CcSEcCtD
Cilazapril—Flushing—Capecitabine—colon cancer	0.000415	0.00225	CcSEcCtD
Cilazapril—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.000414	0.00225	CcSEcCtD
Cilazapril—Decreased appetite—Irinotecan—colon cancer	0.000413	0.00224	CcSEcCtD
Cilazapril—Insomnia—Fluorouracil—colon cancer	0.000411	0.00223	CcSEcCtD
Cilazapril—Gastrointestinal disorder—Irinotecan—colon cancer	0.00041	0.00222	CcSEcCtD
Cilazapril—Fatigue—Irinotecan—colon cancer	0.000409	0.00222	CcSEcCtD
Cilazapril—Paraesthesia—Fluorouracil—colon cancer	0.000408	0.00221	CcSEcCtD
Cilazapril—Pancreatitis—Methotrexate—colon cancer	0.000408	0.00221	CcSEcCtD
Cilazapril—Pain—Irinotecan—colon cancer	0.000406	0.0022	CcSEcCtD
Cilazapril—Constipation—Irinotecan—colon cancer	0.000406	0.0022	CcSEcCtD
Cilazapril—Angiopathy—Capecitabine—colon cancer	0.000406	0.0022	CcSEcCtD
Cilazapril—Dyspnoea—Fluorouracil—colon cancer	0.000405	0.0022	CcSEcCtD
Cilazapril—Somnolence—Fluorouracil—colon cancer	0.000404	0.00219	CcSEcCtD
Cilazapril—Immune system disorder—Capecitabine—colon cancer	0.000404	0.00219	CcSEcCtD
Cilazapril—Chills—Capecitabine—colon cancer	0.000401	0.00218	CcSEcCtD
Cilazapril—Dyspepsia—Fluorouracil—colon cancer	0.0004	0.00217	CcSEcCtD
Cilazapril—Arrhythmia—Capecitabine—colon cancer	0.000399	0.00217	CcSEcCtD
Cilazapril—Gastrointestinal pain—Vincristine—colon cancer	0.000398	0.00216	CcSEcCtD
Cilazapril—Decreased appetite—Fluorouracil—colon cancer	0.000395	0.00214	CcSEcCtD
Cilazapril—Alopecia—Capecitabine—colon cancer	0.000395	0.00214	CcSEcCtD
Cilazapril—Gastrointestinal disorder—Fluorouracil—colon cancer	0.000392	0.00213	CcSEcCtD
Cilazapril—Feeling abnormal—Irinotecan—colon cancer	0.000391	0.00212	CcSEcCtD
Cilazapril—Neutropenia—Methotrexate—colon cancer	0.000389	0.00211	CcSEcCtD
Cilazapril—Dysuria—Methotrexate—colon cancer	0.000389	0.00211	CcSEcCtD
Cilazapril—Pain—Fluorouracil—colon cancer	0.000389	0.00211	CcSEcCtD
Cilazapril—Gastrointestinal pain—Irinotecan—colon cancer	0.000388	0.00211	CcSEcCtD
Cilazapril—ABCB1—lymph node—colon cancer	0.000387	0.0046	CbGeAlD
Cilazapril—Abdominal pain—Vincristine—colon cancer	0.000385	0.00209	CcSEcCtD
Cilazapril—Flatulence—Capecitabine—colon cancer	0.000384	0.00208	CcSEcCtD
Cilazapril—Erectile dysfunction—Methotrexate—colon cancer	0.000383	0.00208	CcSEcCtD
Cilazapril—Dysgeusia—Capecitabine—colon cancer	0.000381	0.00207	CcSEcCtD
Cilazapril—Photosensitivity reaction—Methotrexate—colon cancer	0.00038	0.00206	CcSEcCtD
Cilazapril—Abdominal pain—Irinotecan—colon cancer	0.000375	0.00204	CcSEcCtD
Cilazapril—Feeling abnormal—Fluorouracil—colon cancer	0.000375	0.00203	CcSEcCtD
Cilazapril—Muscle spasms—Capecitabine—colon cancer	0.000374	0.00203	CcSEcCtD
Cilazapril—Stevens-Johnson syndrome—Methotrexate—colon cancer	0.000368	0.00199	CcSEcCtD
Cilazapril—Tremor—Capecitabine—colon cancer	0.000365	0.00198	CcSEcCtD
Cilazapril—Renal failure—Methotrexate—colon cancer	0.000364	0.00198	CcSEcCtD
Cilazapril—Ill-defined disorder—Capecitabine—colon cancer	0.000361	0.00196	CcSEcCtD
Cilazapril—Urticaria—Fluorouracil—colon cancer	0.000361	0.00196	CcSEcCtD
Cilazapril—Conjunctivitis—Methotrexate—colon cancer	0.00036	0.00196	CcSEcCtD
Cilazapril—Anaemia—Capecitabine—colon cancer	0.00036	0.00195	CcSEcCtD
Cilazapril—Hypersensitivity—Vincristine—colon cancer	0.000359	0.00195	CcSEcCtD
Cilazapril—Malaise—Capecitabine—colon cancer	0.000351	0.0019	CcSEcCtD
Cilazapril—Hepatobiliary disease—Methotrexate—colon cancer	0.000351	0.0019	CcSEcCtD
Cilazapril—Epistaxis—Methotrexate—colon cancer	0.00035	0.0019	CcSEcCtD
Cilazapril—Vertigo—Capecitabine—colon cancer	0.00035	0.0019	CcSEcCtD
Cilazapril—Hypersensitivity—Irinotecan—colon cancer	0.00035	0.0019	CcSEcCtD
Cilazapril—Asthenia—Vincristine—colon cancer	0.00035	0.0019	CcSEcCtD
Cilazapril—Syncope—Capecitabine—colon cancer	0.000349	0.00189	CcSEcCtD
Cilazapril—Leukopenia—Capecitabine—colon cancer	0.000348	0.00189	CcSEcCtD
Cilazapril—Agranulocytosis—Methotrexate—colon cancer	0.000346	0.00188	CcSEcCtD
Cilazapril—Palpitations—Capecitabine—colon cancer	0.000344	0.00187	CcSEcCtD
Cilazapril—Loss of consciousness—Capecitabine—colon cancer	0.000342	0.00186	CcSEcCtD
Cilazapril—Asthenia—Irinotecan—colon cancer	0.000341	0.00185	CcSEcCtD
Cilazapril—Cough—Capecitabine—colon cancer	0.00034	0.00184	CcSEcCtD
Cilazapril—Hypertension—Capecitabine—colon cancer	0.000336	0.00182	CcSEcCtD
Cilazapril—Hypersensitivity—Fluorouracil—colon cancer	0.000335	0.00182	CcSEcCtD
Cilazapril—Diarrhoea—Vincristine—colon cancer	0.000333	0.00181	CcSEcCtD
Cilazapril—Chest pain—Capecitabine—colon cancer	0.000331	0.0018	CcSEcCtD
Cilazapril—Myalgia—Capecitabine—colon cancer	0.000331	0.0018	CcSEcCtD
Cilazapril—Arthralgia—Capecitabine—colon cancer	0.000331	0.0018	CcSEcCtD
Cilazapril—Pharyngitis—Methotrexate—colon cancer	0.00033	0.00179	CcSEcCtD
Cilazapril—Anxiety—Capecitabine—colon cancer	0.00033	0.00179	CcSEcCtD
Cilazapril—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—colon cancer	0.000329	0.00179	CcSEcCtD
Cilazapril—Urinary tract disorder—Methotrexate—colon cancer	0.000329	0.00178	CcSEcCtD
Cilazapril—Discomfort—Capecitabine—colon cancer	0.000327	0.00178	CcSEcCtD
Cilazapril—Urethral disorder—Methotrexate—colon cancer	0.000326	0.00177	CcSEcCtD
Cilazapril—Diarrhoea—Irinotecan—colon cancer	0.000325	0.00176	CcSEcCtD
Cilazapril—Dry mouth—Capecitabine—colon cancer	0.000324	0.00176	CcSEcCtD
Cilazapril—Dizziness—Vincristine—colon cancer	0.000322	0.00175	CcSEcCtD
Cilazapril—Pruritus—Fluorouracil—colon cancer	0.000322	0.00174	CcSEcCtD
Cilazapril—Visual impairment—Methotrexate—colon cancer	0.000321	0.00174	CcSEcCtD
Cilazapril—Confusional state—Capecitabine—colon cancer	0.00032	0.00174	CcSEcCtD
Cilazapril—Oedema—Capecitabine—colon cancer	0.000318	0.00172	CcSEcCtD
Cilazapril—Erythema multiforme—Methotrexate—colon cancer	0.000315	0.00171	CcSEcCtD
Cilazapril—Dizziness—Irinotecan—colon cancer	0.000314	0.0017	CcSEcCtD
Cilazapril—Shock—Capecitabine—colon cancer	0.000313	0.0017	CcSEcCtD
Cilazapril—Diarrhoea—Fluorouracil—colon cancer	0.000311	0.00169	CcSEcCtD
Cilazapril—Thrombocytopenia—Capecitabine—colon cancer	0.000311	0.00169	CcSEcCtD
Cilazapril—Tinnitus—Methotrexate—colon cancer	0.00031	0.00168	CcSEcCtD
Cilazapril—Tachycardia—Capecitabine—colon cancer	0.00031	0.00168	CcSEcCtD
Cilazapril—Vomiting—Vincristine—colon cancer	0.00031	0.00168	CcSEcCtD
Cilazapril—Cardiac disorder—Methotrexate—colon cancer	0.000309	0.00168	CcSEcCtD
Cilazapril—Skin disorder—Capecitabine—colon cancer	0.000309	0.00167	CcSEcCtD
Cilazapril—Rash—Vincristine—colon cancer	0.000307	0.00167	CcSEcCtD
Cilazapril—Hyperhidrosis—Capecitabine—colon cancer	0.000307	0.00167	CcSEcCtD
Cilazapril—Dermatitis—Vincristine—colon cancer	0.000307	0.00167	CcSEcCtD
Cilazapril—Headache—Vincristine—colon cancer	0.000305	0.00166	CcSEcCtD
Cilazapril—Anorexia—Capecitabine—colon cancer	0.000303	0.00164	CcSEcCtD
Cilazapril—Angiopathy—Methotrexate—colon cancer	0.000302	0.00164	CcSEcCtD
Cilazapril—Vomiting—Irinotecan—colon cancer	0.000302	0.00164	CcSEcCtD
Cilazapril—Immune system disorder—Methotrexate—colon cancer	0.000301	0.00163	CcSEcCtD
Cilazapril—Dizziness—Fluorouracil—colon cancer	0.000301	0.00163	CcSEcCtD
Cilazapril—Rash—Irinotecan—colon cancer	0.000299	0.00162	CcSEcCtD
Cilazapril—Dermatitis—Irinotecan—colon cancer	0.000299	0.00162	CcSEcCtD
Cilazapril—Chills—Methotrexate—colon cancer	0.000299	0.00162	CcSEcCtD
Cilazapril—Headache—Irinotecan—colon cancer	0.000297	0.00161	CcSEcCtD
Cilazapril—Hypotension—Capecitabine—colon cancer	0.000297	0.00161	CcSEcCtD
Cilazapril—Alopecia—Methotrexate—colon cancer	0.000294	0.0016	CcSEcCtD
Cilazapril—Nausea—Vincristine—colon cancer	0.000289	0.00157	CcSEcCtD
Cilazapril—Musculoskeletal discomfort—Capecitabine—colon cancer	0.000289	0.00157	CcSEcCtD
Cilazapril—Vomiting—Fluorouracil—colon cancer	0.000289	0.00157	CcSEcCtD
Cilazapril—Insomnia—Capecitabine—colon cancer	0.000287	0.00156	CcSEcCtD
Cilazapril—Rash—Fluorouracil—colon cancer	0.000287	0.00156	CcSEcCtD
Cilazapril—Dermatitis—Fluorouracil—colon cancer	0.000286	0.00155	CcSEcCtD
Cilazapril—Paraesthesia—Capecitabine—colon cancer	0.000285	0.00155	CcSEcCtD
Cilazapril—Headache—Fluorouracil—colon cancer	0.000285	0.00155	CcSEcCtD
Cilazapril—Dysgeusia—Methotrexate—colon cancer	0.000284	0.00154	CcSEcCtD
Cilazapril—Dyspnoea—Capecitabine—colon cancer	0.000283	0.00154	CcSEcCtD
Cilazapril—Nausea—Irinotecan—colon cancer	0.000282	0.00153	CcSEcCtD
Cilazapril—Dyspepsia—Capecitabine—colon cancer	0.00028	0.00152	CcSEcCtD
Cilazapril—Decreased appetite—Capecitabine—colon cancer	0.000276	0.0015	CcSEcCtD
Cilazapril—Gastrointestinal disorder—Capecitabine—colon cancer	0.000274	0.00149	CcSEcCtD
Cilazapril—Fatigue—Capecitabine—colon cancer	0.000274	0.00149	CcSEcCtD
Cilazapril—Pain—Capecitabine—colon cancer	0.000272	0.00147	CcSEcCtD
Cilazapril—Constipation—Capecitabine—colon cancer	0.000272	0.00147	CcSEcCtD
Cilazapril—Nausea—Fluorouracil—colon cancer	0.00027	0.00146	CcSEcCtD
Cilazapril—Ill-defined disorder—Methotrexate—colon cancer	0.000269	0.00146	CcSEcCtD
Cilazapril—Anaemia—Methotrexate—colon cancer	0.000268	0.00145	CcSEcCtD
Cilazapril—Feeling abnormal—Capecitabine—colon cancer	0.000262	0.00142	CcSEcCtD
Cilazapril—Malaise—Methotrexate—colon cancer	0.000261	0.00142	CcSEcCtD
Cilazapril—Vertigo—Methotrexate—colon cancer	0.00026	0.00141	CcSEcCtD
Cilazapril—Gastrointestinal pain—Capecitabine—colon cancer	0.00026	0.00141	CcSEcCtD
Cilazapril—Leukopenia—Methotrexate—colon cancer	0.000259	0.00141	CcSEcCtD
Cilazapril—Cough—Methotrexate—colon cancer	0.000253	0.00137	CcSEcCtD
Cilazapril—Urticaria—Capecitabine—colon cancer	0.000252	0.00137	CcSEcCtD
Cilazapril—Abdominal pain—Capecitabine—colon cancer	0.000251	0.00136	CcSEcCtD
Cilazapril—Arthralgia—Methotrexate—colon cancer	0.000247	0.00134	CcSEcCtD
Cilazapril—Chest pain—Methotrexate—colon cancer	0.000247	0.00134	CcSEcCtD
Cilazapril—Myalgia—Methotrexate—colon cancer	0.000247	0.00134	CcSEcCtD
Cilazapril—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—colon cancer	0.000245	0.00133	CcSEcCtD
Cilazapril—Discomfort—Methotrexate—colon cancer	0.000244	0.00132	CcSEcCtD
Cilazapril—Confusional state—Methotrexate—colon cancer	0.000238	0.00129	CcSEcCtD
Cilazapril—Hypersensitivity—Capecitabine—colon cancer	0.000234	0.00127	CcSEcCtD
Cilazapril—Thrombocytopenia—Methotrexate—colon cancer	0.000232	0.00126	CcSEcCtD
Cilazapril—Skin disorder—Methotrexate—colon cancer	0.00023	0.00125	CcSEcCtD
Cilazapril—Hyperhidrosis—Methotrexate—colon cancer	0.000229	0.00124	CcSEcCtD
Cilazapril—Asthenia—Capecitabine—colon cancer	0.000228	0.00124	CcSEcCtD
Cilazapril—Anorexia—Methotrexate—colon cancer	0.000225	0.00122	CcSEcCtD
Cilazapril—Pruritus—Capecitabine—colon cancer	0.000225	0.00122	CcSEcCtD
Cilazapril—Hypotension—Methotrexate—colon cancer	0.000221	0.0012	CcSEcCtD
Cilazapril—Diarrhoea—Capecitabine—colon cancer	0.000217	0.00118	CcSEcCtD
Cilazapril—Musculoskeletal discomfort—Methotrexate—colon cancer	0.000215	0.00117	CcSEcCtD
Cilazapril—Insomnia—Methotrexate—colon cancer	0.000214	0.00116	CcSEcCtD
Cilazapril—Paraesthesia—Methotrexate—colon cancer	0.000212	0.00115	CcSEcCtD
Cilazapril—Dyspnoea—Methotrexate—colon cancer	0.000211	0.00114	CcSEcCtD
Cilazapril—Somnolence—Methotrexate—colon cancer	0.00021	0.00114	CcSEcCtD
Cilazapril—Dizziness—Capecitabine—colon cancer	0.00021	0.00114	CcSEcCtD
Cilazapril—Dyspepsia—Methotrexate—colon cancer	0.000208	0.00113	CcSEcCtD
Cilazapril—Decreased appetite—Methotrexate—colon cancer	0.000206	0.00112	CcSEcCtD
Cilazapril—Gastrointestinal disorder—Methotrexate—colon cancer	0.000204	0.00111	CcSEcCtD
Cilazapril—Fatigue—Methotrexate—colon cancer	0.000204	0.00111	CcSEcCtD
Cilazapril—Pain—Methotrexate—colon cancer	0.000202	0.0011	CcSEcCtD
Cilazapril—Vomiting—Capecitabine—colon cancer	0.000202	0.0011	CcSEcCtD
Cilazapril—Rash—Capecitabine—colon cancer	0.0002	0.00109	CcSEcCtD
Cilazapril—Dermatitis—Capecitabine—colon cancer	0.0002	0.00109	CcSEcCtD
Cilazapril—Headache—Capecitabine—colon cancer	0.000199	0.00108	CcSEcCtD
Cilazapril—Feeling abnormal—Methotrexate—colon cancer	0.000195	0.00106	CcSEcCtD
Cilazapril—Gastrointestinal pain—Methotrexate—colon cancer	0.000193	0.00105	CcSEcCtD
Cilazapril—Nausea—Capecitabine—colon cancer	0.000189	0.00102	CcSEcCtD
Cilazapril—Urticaria—Methotrexate—colon cancer	0.000188	0.00102	CcSEcCtD
Cilazapril—Abdominal pain—Methotrexate—colon cancer	0.000187	0.00101	CcSEcCtD
Cilazapril—Hypersensitivity—Methotrexate—colon cancer	0.000174	0.000945	CcSEcCtD
Cilazapril—Asthenia—Methotrexate—colon cancer	0.00017	0.000921	CcSEcCtD
Cilazapril—Pruritus—Methotrexate—colon cancer	0.000167	0.000908	CcSEcCtD
Cilazapril—Diarrhoea—Methotrexate—colon cancer	0.000162	0.000878	CcSEcCtD
Cilazapril—Dizziness—Methotrexate—colon cancer	0.000156	0.000848	CcSEcCtD
Cilazapril—Vomiting—Methotrexate—colon cancer	0.00015	0.000816	CcSEcCtD
Cilazapril—Rash—Methotrexate—colon cancer	0.000149	0.000809	CcSEcCtD
Cilazapril—Dermatitis—Methotrexate—colon cancer	0.000149	0.000808	CcSEcCtD
Cilazapril—Headache—Methotrexate—colon cancer	0.000148	0.000804	CcSEcCtD
Cilazapril—Nausea—Methotrexate—colon cancer	0.00014	0.000762	CcSEcCtD
